UK signs deal for 60-million Sanofi/GSK vaccine doses
This is the fourth such deal amid worries that rich countries, such as the US and UK, are securing vaccine doses at the expense of poorer ones
29 July 2020 - 16:46
London/Paris — Britain has signed a deal for up to 60-million doses of a potential coronavirus vaccine being developed by Sanofi and GlaxoSmithKline (GSK), it said on Wednesday, its latest such arrangement as the race to tame the pandemic heats up.
With its four deals so far, Britain has struck more coronavirus vaccine supply agreements than any other country, securing 250-million doses for a population of 66-million. But with no vaccine yet proven, a range of potential suppliers is seen as giving the best chance of success...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.